Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Edeleny – page 13

161 clinical trials in Edeleny, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Edeleny at a glance
161
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

161 trials in Edeleny

Open in trial search

Dysmenorrhoea

Not recruiting

Study on the Effectiveness of Chaste Tree Extract (Vitex agnus-castus BNO 1095) for Women with Menstrual Cramps (Primary Dysmenorrhea)

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Dry Extract From Chaste Tree Fruits (7-11:1), Extraction Solvent: Ethanol 70% (V/V)
  • Sponsor:Bionorica SE

Chronic hepatitis B+1

Not recruiting

Study of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Bepirovirsen
  • Sponsor:Glaxosmithkline Research & Development Limited

Breast cancer+2

Not recruiting

Study on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:F. Hoffmann-La Roche AG

Dyslipidaemia

Not recruiting

Study on the Effects of AZD0780 on Cholesterol Levels in Adults Aged 18-75 with Dyslipidemia

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:Astrazeneca AB

Psoriasis

Not recruiting

Study on Guselkumab and Etanercept for Treating Chronic Plaque Psoriasis in Children Aged 6 to 17 Years

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Etanercept
  • Sponsor:Janssen - Cilag International

Study on Ertugliflozin for Children and Teens with Type 2 Diabetes

Investigational
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ertugliflozin
  • Sponsor:Merck Sharp & Dohme LLC

Bladder cancer

Not recruiting

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen - Cilag International

Study of Chemotherapy With Pembrolizumab and Olaparib for Patients With Advanced Epithelial Ovarian Cancer Without BRCA Mutation

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Anhydrous Docetaxel
  • Sponsor:Merck Sharp & Dohme LLC

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen - Cilag International

Type 2 diabetes mellitus+3

Not recruiting

Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Canagliflozin
  • Sponsor:Eli Lilly & Co.

Colitis ulcerative

Not recruiting

Study on Ustekinumab for Children with Moderate to Severe Ulcerative Colitis

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ustekinumab
  • Sponsor:Janssen - Cilag International

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Edeleny

What the registry says about research in the country

01 Asthma Research

Innovative clinical trials focusing on moderate-to-severe asthma management, investigating new therapeutic approaches for patients with uncontrolled symptoms.

  • Long-term lung function preservation
  • Exacerbation reduction therapies
  • Novel biological treatments

Multiple studies are evaluating medications like amlitelimab and dexpramipexole for improving patient outcomes.

02 COPD Studies

Comprehensive research into Chronic Obstructive Pulmonary Disease treatments, examining both established and experimental therapies.

  • Triple therapy combinations
  • Exacerbation management
  • Long-term safety assessments

Trials are investigating various treatment approaches including bronchodilator combinations and targeted biological therapies.

03 Respiratory Innovations

Advanced research combining therapeutic approaches for both asthma and COPD, with a focus on personalized medicine solutions.

  • Maintenance therapy optimization
  • Biological treatment development
  • Patient-specific responses

Studies aim to improve quality of life through innovative treatment combinations and targeted interventions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.